NCT02749383View on ClinicalTrials.gov

A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Seborrheic Dermatitis

PHASE2CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

October 31, 2015

Conditions
Seborrheic Dermatitis
Interventions
DRUG

PAC-14028 cream 0.3%

Topical application

DRUG

PAC-14028 cream 1.0%

Topical application

DRUG

PAC-14028 cream vehicle

Topical application

All Listed Sponsors
lead

Amorepacific Corporation

INDUSTRY

NCT02749383 - A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Seborrheic Dermatitis | Biotech Hunter | Biotech Hunter